{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:20:34Z","timestamp":1767644434160,"version":"3.48.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Key Research and Development Program of Zhejiang Province","award":["2024C03281(SD2)"],"award-info":[{"award-number":["2024C03281(SD2)"]}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2022020304"],"award-info":[{"award-number":["2022020304"]}]},{"name":"Ningbo Clinical Research Center for Emergency and Critical Diseases","award":["2024L003"],"award-info":[{"award-number":["2024L003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03521-3","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:48:30Z","timestamp":1764611310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2\/PI3K\/NLRP3 pathway in Moyamoya disease"],"prefix":"10.1186","volume":"31","author":[{"given":"Liangzhe","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinpeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"8","key":"3521_CR1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747\u201358.","journal-title":"Lancet Neurol"},{"key":"3521_CR2","doi-asserted-by":"crossref","unstructured":"Mineharu Y, et al. Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in Moyamoya disease. Stroke Vasc Neurol, 2025.","DOI":"10.1101\/2024.06.22.24306750"},{"issue":"3","key":"3521_CR3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1227\/neu.0000000000002455","volume":"93","author":"T Chen","year":"2023","unstructured":"Chen T, et al. The progression of pathophysiology of Moyamoya disease. Neurosurgery. 2023;93(3):502\u20139.","journal-title":"Neurosurgery"},{"issue":"2","key":"3521_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1570159X19666210716114016","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Progression in Moyamoya disease: clinical features, neuroimaging evaluation, and treatment. Curr Neuropharmacol. 2022;20(2):292\u2013308.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"3521_CR5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/STROKEAHA.117.018563","volume":"49","author":"G Acker","year":"2018","unstructured":"Acker G, Fekonja L, Vajkoczy P. Surgical management of Moyamoya disease. Stroke. 2018;49(2):476\u201382.","journal-title":"Stroke"},{"issue":"4","key":"3521_CR6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/svn-2021-000909","volume":"6","author":"Y Sun","year":"2021","unstructured":"Sun Y, et al. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study. Stroke Vasc Neurol. 2021;6(4):615\u201323.","journal-title":"Stroke Vasc Neurol"},{"issue":"4","key":"3521_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, et al. 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo). 2022;62(4):165\u201370.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"6","key":"3521_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3340\/jkns.2015.57.6.390","volume":"57","author":"T Kim","year":"2015","unstructured":"Kim T, et al. Epidemiology of Moyamoya disease in Korea: based on National Health Insurance Service data. J Korean Neurosurg Soc. 2015;57(6):390\u20135.","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"3521_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens R, et al. The genetic basis of Moyamoya disease. Transl Stroke Res. 2022;13(1):25\u201345.","journal-title":"Transl Stroke Res"},{"key":"3521_CR10","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, et al. Ring finger protein 213 in Moyamoya disease with pulmonary arterial hypertension: a mini-review. Front Neurol. 2022;13:843927.","journal-title":"Front Neurol"},{"issue":"11","key":"3521_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, et al. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28(11):939\u201350.","journal-title":"Trends Mol Med"},{"issue":"2","key":"3521_CR12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1227\/01.NEU.0000249275.87310.FF","volume":"60","author":"Y Takagi","year":"2007","unstructured":"Takagi Y, et al. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease. Neurosurgery. 2007;60(2):338\u201345.","journal-title":"Neurosurgery"},{"issue":"11","key":"3521_CR13","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1177\/0271678X18768443","volume":"38","author":"KG Blecharz-Lang","year":"2018","unstructured":"Blecharz-Lang KG, et al. Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease. J Cereb Blood Flow Metab. 2018;38(11):1940\u201353.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"3521_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"K Tokairin","year":"2020","unstructured":"Tokairin K, et al. Vascular smooth muscle cell derived from IPS cell of Moyamoya disease: comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis. 2020;29(12):105305.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3521_CR15","volume":"13","author":"K Kang","year":"2022","unstructured":"Kang K, et al. MicroRNA expression in circulating leukocytes and bioinformatic analysis of patients with Moyamoya disease. Front Genet. 2022;13:816919.","journal-title":"Front Genet"},{"key":"3521_CR16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3521_CR17","first-page":"72","volume":"2","author":"S Dogra","year":"2025","unstructured":"Dogra S, et al. Development of a miRNA-based deep learning model for autism spectrum disorder diagnosis. Advanced Technology in Neuroscience. 2025;2(2):72\u20136.","journal-title":"Advanced Technology in Neuroscience"},{"key":"3521_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neumar.2024.100001","author":"B Martinez","year":"2024","unstructured":"Martinez B, Peplow PV. MicroRNAs as potential biomarkers for diagnosis of major depressive disorder and influence of antidepressant treatment. NeuroMarkers. 2024. https:\/\/doi.org\/10.1016\/j.neumar.2024.100001.","journal-title":"NeuroMarkers"},{"issue":"1","key":"3521_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s43657-021-00032-z","volume":"2","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Recent progresses in electrochemical DNA biosensors for MicroRNA detection. Phenomics. 2022;2(1):18\u201332.","journal-title":"Phenomics"},{"key":"3521_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233792","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. CircZXDC promotes vascular smooth muscle cell transdifferentiation via regulating miRNA-125a-3p\/ABCC6 in Moyamoya disease. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233792.","journal-title":"Cells"},{"issue":"11","key":"3521_CR21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1177\/0271678X221110679","volume":"42","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses. J Cereb Blood Flow Metab. 2022;42(11):2107\u201322.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"3521_CR22","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.041","volume":"24","author":"S Zhao","year":"2015","unstructured":"Zhao S, et al. Elevated serum microRNA let-7c in Moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(8):1709\u201314.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"13","key":"3521_CR23","doi-asserted-by":"crossref","first-page":"13234","DOI":"10.18632\/aging.103431","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen C, et al. Increasing the expression of microRNA-126-5p in the temporal muscle can promote angiogenesis in the chronically ischemic brains of rats subjected to two-vessel occlusion plus encephalo-myo-synangiosis. Aging (Albany NY). 2020;12(13):13234\u201354.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3521_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/or.2020.7832","volume":"45","author":"L Wang","year":"2021","unstructured":"Wang L, Mu N, Qu N. Methylation of the miR-29b-3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer. Oncol Rep. 2021;45(1):65\u201372.","journal-title":"Oncol Rep"},{"issue":"8","key":"3521_CR25","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00701-023-05579-6","volume":"165","author":"S Ota","year":"2023","unstructured":"Ota S, et al. Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing. Acta Neurochir. 2023;165(8):2045\u201355.","journal-title":"Acta Neurochir"},{"issue":"1","key":"3521_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11658-023-00432-1","volume":"28","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Exosomal Mir-3613-3p derived from oxygen-glucose deprivation-treated brain microvascular endothelial cell promotes microglial M1 polarization. Cell Mol Biol Lett. 2023;28(1):18.","journal-title":"Cell Mol Biol Lett"},{"issue":"17","key":"3521_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, et al. The multiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42(17):e133. https:\/\/doi.org\/10.1093\/nar\/gku631.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3521_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311.","journal-title":"J Stroke"},{"issue":"11","key":"3521_CR29","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056\u201366.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3521_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2012.05.062","volume":"521","author":"YS Park","year":"2012","unstructured":"Park YS, et al. Association of the miR-146aC>G, miR-196a2C>T, and miR-499A>G polymorphisms with Moyamoya disease in the Korean population. Neurosci Lett. 2012;521(1):71\u20135.","journal-title":"Neurosci Lett"},{"issue":"8","key":"3521_CR31","volume":"9","author":"D Dai","year":"2014","unstructured":"Dai D, et al. Serum miRNA signature in Moyamoya disease. PLoS ONE. 2014;9(8):e102382.","journal-title":"PLoS ONE"},{"issue":"8","key":"3521_CR32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00701-023-05579-6","volume":"165","author":"S Ota","year":"2023","unstructured":"Ota S, et al. Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing. Acta Neurochir (Wien). 2023;165(8):2045\u201355.","journal-title":"Acta Neurochir (Wien)"},{"key":"3521_CR33","volume":"14","author":"G Wang","year":"2020","unstructured":"Wang G, et al. A panel of exosome-derived miRNAs of cerebrospinal fluid for the diagnosis of Moyamoya disease. Front Neurosci. 2020;14:548278.","journal-title":"Front Neurosci"},{"key":"3521_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168952","author":"C Santoro","year":"2022","unstructured":"Santoro C, et al. Mystery(n) phenotypic presentation in Europeans: report of three further novel missense RNF213 variants leading to severe syndromic forms of Moyamoya angiopathy and literature review. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23168952.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3521_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220858","volume":"14","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, et al. Identification of HLA-DRB1*04:10 allele as risk allele for Japanese Moyamoya disease and its association with autoimmune thyroid disease: a case\u2013control study. PLoS ONE. 2019;14(8):e0220858.","journal-title":"PLoS ONE"},{"key":"3521_CR36","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. TGFbeta1 as a predictive biomarker for collateral formation within ischemic Moyamoya disease. Front Neurol. 2022;13:899470.","journal-title":"Front Neurol"},{"key":"3521_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-023-01149-1","author":"K Abhinav","year":"2023","unstructured":"Abhinav K, et al. Correction to: comprehensive profiling of secreted factors in the cerebrospinal fluid of Moyamoya disease patients. Transl Stroke Res. 2023. https:\/\/doi.org\/10.1007\/s12975-023-01149-1.","journal-title":"Transl Stroke Res"},{"issue":"12","key":"3521_CR38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"},{"issue":"1","key":"3521_CR39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Fujimura M, Kim SK. The pathophysiology of Moyamoya disease: an update. J Stroke. 2016;18(1):12\u201320.","journal-title":"J Stroke"},{"key":"3521_CR40","doi-asserted-by":"crossref","first-page":"42421","DOI":"10.1038\/srep42421","volume":"7","author":"W Wang","year":"2017","unstructured":"Wang W, et al. Integrated analysis of LncRNA\u2013mRNA co-expression profiles in patients with Moyamoya disease. Sci Rep. 2017;7:42421.","journal-title":"Sci Rep"},{"key":"3521_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.661578","volume":"12","author":"BM Fox","year":"2021","unstructured":"Fox BM, Dorschel KB, Lawton MT, Wanebo JE. Pathophysiology of vascular stenosis and remodeling in Moyamoya disease. Front Neurol. 2021;12:661578. https:\/\/doi.org\/10.3389\/fneur.2021.661578.","journal-title":"Front Neurol"},{"issue":"10","key":"3521_CR42","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1177\/0271678X241245557","volume":"44","author":"HS Shin","year":"2024","unstructured":"Shin HS, et al. RNF213 variant and autophagic impairment: a pivotal link to endothelial dysfunction in Moyamoya disease. J Cereb Blood Flow Metab. 2024;44(10):1801\u201315.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"3521_CR43","volume":"6","author":"S He","year":"2025","unstructured":"He S, et al. Advances in Moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions. MedComm. 2025;6(2):e70054.","journal-title":"MedComm"},{"issue":"1","key":"3521_CR44","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/STROKEAHA.123.045064","volume":"55","author":"X Ruan","year":"2024","unstructured":"Ruan X, et al. Insights on Moyamoya disease: vascular inflammation and nuclear autoschizis in cranial arteries. Stroke. 2024;55(1):e5\u20137.","journal-title":"Stroke"},{"key":"3521_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015142","author":"Y Ma","year":"2023","unstructured":"Ma Y, et al. Biological evaluation of 8-methoxy-2,5-dimethyl-5H-indolo[2,3-b] quinoline as a potential antitumor agent via PI3K\/AKT\/mTOR signaling. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242015142.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3521_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113026","volume":"412","author":"J Yang","year":"2022","unstructured":"Yang J, Gao J, Gao F, Zhao Yi, Deng B, Mu X, et al. Extracellular vesicles-encapsulated microRNA-29b-3p from bone marrow-derived mesenchymal stem cells promotes fracture healing via modulation of the PTEN\/PI3K\/AKT axis. Exp Cell Res. 2022;412(2):113026. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113026.","journal-title":"Exp Cell Res"},{"issue":"11","key":"3521_CR47","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/brain\/awad225","volume":"146","author":"F Ye","year":"2023","unstructured":"Ye F, et al. Rnf213 loss-of-function promotes pathological angiogenesis in Moyamoya disease via the Hippo pathway. Brain. 2023;146(11):4674\u201389.","journal-title":"Brain"},{"issue":"4","key":"3521_CR48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/0271678X16658301","volume":"37","author":"KG Blecharz","year":"2017","unstructured":"Blecharz KG, et al. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab. 2017;37(4):1527\u201339.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"3521_CR49","first-page":"1845","volume":"116","author":"M Rao","year":"2003","unstructured":"Rao M, et al. Clinical and experimental pathology of Moyamoya disease. Chin Med J (Engl). 2003;116(12):1845\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"3521_CR50","volume":"13","author":"J Han","year":"2022","unstructured":"Han J, et al. Artemisinin relieves myocardial ischemia\u2013reperfusion injury via modulating miR-29b-3p and hemicentin 1. Front Pharmacol. 2022;13:918966.","journal-title":"Front Pharmacol"},{"key":"3521_CR51","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.259696","author":"L Pu","year":"2022","unstructured":"Pu L, et al. Laminar shear stress alleviates monocyte adhesion and atherosclerosis development via miR-29b-3p\/CX3CL1 axis regulation. J Cell Sci. 2022. https:\/\/doi.org\/10.1242\/jcs.259696.","journal-title":"J Cell Sci"},{"issue":"6","key":"3521_CR52","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s10528-022-10194-8","volume":"60","author":"Y Tong","year":"2022","unstructured":"Tong Y, et al. MiR-29b-3p inhibits the inflammation injury in human umbilical vein endothelial cells by regulating SEC23A. Biochem Genet. 2022;60(6):2000\u201314.","journal-title":"Biochem Genet"},{"issue":"8","key":"3521_CR53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12012-022-09745-7","volume":"22","author":"J Zheng","year":"2022","unstructured":"Zheng J, et al. Bone marrow mesenchymal stem cell-derived exosomal microRNA-29b-3p promotes angiogenesis and ventricular remodeling in rats with myocardial infarction by targeting ADAMTS16. Cardiovasc Toxicol. 2022;22(8):689\u2013700.","journal-title":"Cardiovasc Toxicol"},{"key":"3521_CR54","first-page":"64","volume":"26","author":"W Tang","year":"2020","unstructured":"Tang W, et al. MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells. Mol Vis. 2020;26:64\u201375.","journal-title":"Mol Vis"},{"issue":"2","key":"3521_CR55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cns.13043","volume":"25","author":"XG Li","year":"2019","unstructured":"Li XG, Wang YB. SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K\/Akt signaling pathway in a rat model of intracranial aneurysms. CNS Neurosci Ther. 2019;25(2):233\u201344.","journal-title":"CNS Neurosci Ther"},{"key":"3521_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168822","author":"CH Pan","year":"2021","unstructured":"Pan CH, et al. Pathological role of phosphoglycerate kinase 1 in balloon angioplasty-induced neointima formation. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168822.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3521_CR57","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/ATVBAHA.115.307110","volume":"36","author":"H Wu","year":"2016","unstructured":"Wu H, et al. Cathepsin S activity controls injury-related vascular repair in mice via the TLR2-mediated p38MAPK and PI3K\u2013Akt\/p-HDAC6 signaling pathway. Arterioscler Thromb Vasc Biol. 2016;36(8):1549\u201357.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3521_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1647","volume":"14","author":"P Ge","year":"2024","unstructured":"Ge P, Tao C, Wang W, He Q, Liu C, Zheng Z, et al. Circulating immune cell landscape and T-cell abnormalities in patients with Moyamoya disease. Clin Transl Med. 2024;14(4):e1647. https:\/\/doi.org\/10.1002\/ctm2.1647.","journal-title":"Clin Transl Med"},{"key":"3521_CR59","doi-asserted-by":"crossref","first-page":"1123951","DOI":"10.3389\/fneur.2023.1123951","volume":"14","author":"E Liu","year":"2023","unstructured":"Liu E, et al. Clinical value of the systemic immune-inflammation index in Moyamoya disease. Front Neurol. 2023;14:1123951.","journal-title":"Front Neurol"},{"issue":"1","key":"3521_CR60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-025-03479-3","volume":"22","author":"C Liu","year":"2025","unstructured":"Liu C, et al. Circulating T cell atlas in Moyamoya disease: insights into immunopathogenesis of cerebrovascular disorders. J Neuroinflammation. 2025;22(1):151.","journal-title":"J Neuroinflammation"},{"key":"3521_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.918805","volume":"13","author":"WH Chen","year":"2022","unstructured":"Chen WH, Huang Q-y, Wang Z-y, Zhuang X-X, Lin S, Shi Q-Y. Therapeutic potential of exosomes\/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms. Front Endocrinol (Lausanne). 2022;13:918805. https:\/\/doi.org\/10.3389\/fendo.2022.918805.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"3521_CR62","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1007\/s12035-025-05103-0","volume":"62","author":"J Shen","year":"2025","unstructured":"Shen J, et al. RNF213 knockdown and inflammation promote angiogenesis and phenotype switching by JAK2\/STAT3 pathway in Moyamoya disease. Mol Neurobiol. 2025;62(10):12938\u201350.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3521_CR63","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2020.02.024","volume":"525","author":"M Takeda","year":"2020","unstructured":"Takeda M, et al. Moyamoya disease patient mutations in the RING domain of RNF213 reduce its ubiquitin ligase activity and enhance NF\u03baB activation and apoptosis in an AAA+ domain-dependent manner. Biochem Biophys Res Commun. 2020;525(3):668\u201374.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03521-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:22:39Z","timestamp":1767633759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03521-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3521"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03521-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of First Affiliated Hospital of Ningbo University reviewed and approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}